Robert W. Baird Cuts Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $33.00
Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price lowered by Robert W. Baird from $37.00 to $33.00 in a research note issued to investors on Thursday,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical device company’s stock. A number of other brokerages have also weighed in on TNDM. […]
Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price lowered by Robert W. Baird from $37.00 to $33.00 in a research note issued to investors on Thursday,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical device company’s stock. A number of other brokerages have also weighed in on TNDM. […]
